Morpholino

MO4-sulf1

ID

ZDB-MRPHLNO-140321-2

Name

MO4-sulf1

Previous Names

S1-SB (1)

Target

sulf1 (1)

Sequence

5' - GTAGTCCTGGTAGTGGTAGAATAAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO4-sulf1

Expressed Gene	Anatomy	Figures
sulf2a	whole organism	Fig. 2 from Schenk et al., 2019
sulf2b	whole organism	Fig. 2 from Schenk et al., 2019

Phenotype

Phenotype resulting from MO4-sulf1

Phenotype	Fish	Figures
axial vasculature blood circulation disrupted, abnormal	WT + MO4-sulf1	Fig. 4 from Gorsi et al., 2014
caudal artery dissociated from caudal vein, abnormal	zf3202Tg + MO4-sulf1	Fig. 1 from Schenk et al., 2019
caudal fin curved, abnormal	lri500Tg + MO4-sulf1	Fig. 2 from Schenk et al., 2019
caudal fin blood circulation decreased occurrence, abnormal	WT + MO4-sulf1	Fig. 1 from Schenk et al., 2019
cranial vasculature blood circulation disrupted, abnormal	WT + MO4-sulf1	Fig. 4 from Gorsi et al., 2014
glomerular filtration process quality, abnormal	lri500Tg + MO4-sulf1	Fig. 2 from Schenk et al., 2019
optic choroid vascular plexus EGFP expression decreased amount, abnormal	lri500Tg + MO4-sulf1	Fig. 2 from Schenk et al., 2019
pericardium edematous, abnormal	lri500Tg + MO4-sulf1	Fig. 2 from Schenk et al., 2019
post-vent vasculature morphology, abnormal	WT + MO4-sulf1	Fig. 1 from Schenk et al., 2019
pronephric glomerular basement membrane structure, abnormal	WT + MO4-sulf1	Fig. 3 from Schenk et al., 2019
pronephric glomerulus morphology, abnormal	WT + MO4-sulf1	Fig. 3 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO4-sulf1	Fig. 3 from Schenk et al., 2019
whole organism sulf2a expression increased amount, abnormal	WT + MO4-sulf1	Fig. 2 from Schenk et al., 2019
whole organism sulf2b expression increased amount, abnormal	WT + MO4-sulf1	Fig. 2 from Schenk et al., 2019
yolk edematous, abnormal	lri500Tg + MO4-sulf1	Fig. 2 from Schenk et al., 2019

Phenotype of all Fish created by or utilizing MO4-sulf1

Phenotype	Fish	Conditions	Figures
pronephric glomerular basement membrane structure, abnormal	WT + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
cranial vasculature blood circulation disrupted, abnormal	WT + MO4-sulf1	standard conditions	Fig. 4 from Gorsi et al., 2014
axial vasculature blood circulation disrupted, abnormal	WT + MO4-sulf1	standard conditions	Fig. 4 from Gorsi et al., 2014
pronephric glomerulus morphology, abnormal	WT + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
caudal fin blood circulation decreased occurrence, abnormal	WT + MO4-sulf1	control	Fig. 1 from Schenk et al., 2019
post-vent vasculature morphology, abnormal	WT + MO4-sulf1	control	Fig. 1 from Schenk et al., 2019
whole organism sulf2b expression increased amount, abnormal	WT + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
whole organism sulf2a expression increased amount, abnormal	WT + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
optic choroid vascular plexus EGFP expression decreased amount, abnormal	lri500Tg + MO4-sulf1	physical alteration: pronephric glomerulus, chemical treatment by environment: 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	Fig. 7 from Schenk et al., 2019
pericardium edematous, abnormal	lri500Tg + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
yolk edematous, abnormal	lri500Tg + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
caudal fin curved, abnormal	lri500Tg + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
glomerular filtration process quality, abnormal	lri500Tg + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
optic choroid vascular plexus EGFP expression decreased amount, abnormal	lri500Tg + MO4-sulf1	control	Fig. 2 from Schenk et al., 2019
glomerular filtration process quality, abnormal	lri500Tg + MO4-sulf1	physical alteration: pronephric glomerulus, chemical treatment by environment: 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	Fig. 7 from Schenk et al., 2019
caudal artery dissociated from caudal vein, abnormal	zf3202Tg + MO4-sulf1	control	Fig. 1 from Schenk et al., 2019
pronephric glomerular basement membrane structure, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
pronephric glomerulus morphology, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019

Citations